CNS Pharmaceuticals, Inc.(CNSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNSP CNS Pharmaceuticals, Inc.

交易中 12-15 11:22:45 EST

7.48

-0.31

-3.98%

最高7.77	最低7.01	成交量2,495
今开7.51	昨收7.79	日振幅9.76%
总市值463.98万	流通市值403.55万	总股本62.03万
成交额1.86万	换手率0.46%	流通股本53.95万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNSP","market":"US","secType":"STK","nameCN":"CNS Pharmaceuticals, Inc.","latestPrice":7.48,"timestamp":1765815548431,"preClose":7.79,"halted":0,"volume":2495,"delay":0,"floatShares":539500,"shares":620300,"eps":-85.406334,"marketStatus":"交易中","change":-0.31,"latestTime":"12-15 11:22:45 EST","open":7.51,"high":7.7707,"low":7.0101,"amount":18582.218585000002,"amplitude":0.097638,"askPrice":7.88,"askSize":11,"bidPrice":7.03,"bidSize":7,"shortable":0,"etf":0,"ttmEps":-85.406334,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":7.79,"postHourTrading":{"tag":"盘后","latestPrice":7.79,"preClose":7.79,"latestTime":"16:10 EST","volume":2,"amount":15.58,"timestamp":1765573803920},"volumeRatio":0.405074},"requestUrl":"/m/hq/s/CNSP/wiki","defaultTab":"wiki","newsList":[{"id":"2557304324","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557304324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557304324?lang=zh_cn&edition=full","pubTime":"2025-08-07 03:40","pubTimestamp":1754509208,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日03时40分，Cns Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.24%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Biomx Inc.、Avidity Biosciences, Inc.、Rigel Pharmaceuticals, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为776.82%、720.91%、127.15%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Cingulate Inc C/Wts 10/12/2026 、Biomx Inc.，振幅分别为57.18%、51.96%、51.84%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080703400994d3fe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080703400994d3fe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2556738764","title":"Cns Pharmaceuticals, Inc.盘中异动 快速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556738764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556738764?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:34","pubTimestamp":1754314455,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时34分，Cns Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.19%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Soligenix, Inc.涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2462.75%、858.62%、404.37%，振幅较大的相关个股有Psyence Biomedical Ltd.、Soligenix, Inc.、凯信远达，振幅分别为30.72%、20.98%、15.35%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213415a6d28434&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213415a6d28434&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2555028267","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘急速下跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555028267?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:53","pubTimestamp":1753887232,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时53分，Cns Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.04%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225352a6c9eec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225352a6c9eec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2555057703","title":"Cns Pharmaceuticals, Inc.盘中异动 大幅跳水5.10%报8.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555057703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555057703?lang=zh_cn&edition=full","pubTime":"2025-07-29 01:01","pubTimestamp":1753722099,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日01时01分，Cns Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.10%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729010139a468170f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729010139a468170f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2552336487","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘快速拉升6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552336487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552336487?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:11","pubTimestamp":1752761464,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时11分，Cns Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.00%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717221104a45151a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717221104a45151a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2550595749","title":"Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550595749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550595749?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:46","pubTimestamp":1752248765,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日23时46分，Cns Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.74%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Mink Therapeutics, Inc.、Cel-Sci Corporation、Alterity Therapeutics Limited涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为614.76%、425.26%、85.88%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为495.47%、79.84%、35.73%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711234606a6a42c74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711234606a6a42c74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2548816474","title":"Cns Pharmaceuticals, Inc.盘中异动 临近午盘急速上涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548816474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548816474?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:40","pubTimestamp":1751470843,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时40分，Cns Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.75%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702234043a72aebe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702234043a72aebe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2546223511","title":"Cns Pharmaceuticals, Inc.盘中异动 大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546223511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546223511?lang=zh_cn&edition=full","pubTime":"2025-06-26 03:08","pubTimestamp":1750878511,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日03时08分，Cns Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.01%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626030831952b862b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626030831952b862b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2545238463","title":"CNS Pharmaceuticals宣布举办虚拟投资者KOL连线环节，讨论多形性胶质母细胞瘤（GBM）及主要候选产品TPI 287CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme GBM and Lead Product Candidate TPI 287","url":"https://stock-news.laohu8.com/highlight/detail?id=2545238463","media":"动脉网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545238463?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:25","pubTimestamp":1750771500,"startTime":"0","endTime":"0","summary":"The Virtual Investor KOL Connect segment featuring CNS Pharma is now available虚拟投资者KOL Connect关于CNS Pharma的片段现已上线。About CNS Pharmaceuticals, Inc.关于CNS制药公司CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system.CNS Pharmaceuticals是一家临床阶段的制药公司，正在开发一系列用于治疗原发性和转移性脑及中枢神经系统癌症的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624212913978ce7db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624212913978ce7db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","KOL","CNS","BK4007","BK4135"],"gpt_icon":0},{"id":"2543638549","title":"Cns Pharmaceuticals, Inc.盘中异动 快速下跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543638549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543638549?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:04","pubTimestamp":1749823460,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时04分，Cns Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.09%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613220420a4a7944a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613220420a4a7944a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2542322387","title":"Cns Pharmaceuticals, Inc.6月10日成交额为26.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542322387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542322387?lang=zh_cn&edition=full","pubTime":"2025-06-11 09:32","pubTimestamp":1749605544,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Cns Pharmaceuticals, Inc.成交额为26.52万美元，成交额较昨日增加41.65%，当日成交量为26.48万股。Cns Pharmaceuticals, Inc.于2025年6月10日跌4.85%，报0.98美元，该股过去5个交易日跌2.97%，年初至今跌83.67%，过去60日跌68.59%。该公司参与了 Berubicin 的开发，它是一种治疗胶质母细胞瘤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093503a4a2b1c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2542357990","title":"Cns Pharmaceuticals, Inc.6月9日成交额为18.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542357990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542357990?lang=zh_cn&edition=full","pubTime":"2025-06-10 09:31","pubTimestamp":1749519115,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日，Cns Pharmaceuticals, Inc.成交额为18.72万美元，成交额较昨日减少11.34%，当日成交量为18.32万股。Cns Pharmaceuticals, Inc.于2025年6月9日跌0.96%，报1.03美元，该股过去5个交易日涨3.0%，年初至今跌82.83%，过去60日跌61.99%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-09|18.72万|-11.34%|18.32万|#|2025-06-06|21.11万|20.95%|20.24万|#|2025-06-05|17.46万|0.56%|17.19万|#|2025-06-04|17.36万|-58.16%|16.69万|#|2025-06-03|41.49万|16.71%|41.11万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610093610a4a1231a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610093610a4a1231a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2541892802","title":"Cns Pharmaceuticals, Inc.6月6日成交额为21.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541892802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541892802?lang=zh_cn&edition=full","pubTime":"2025-06-07 09:31","pubTimestamp":1749259886,"startTime":"0","endTime":"0","summary":"美东时间2025年6月6日，Cns Pharmaceuticals, Inc.成交额为21.11万美元，成交额较昨日增加20.95%，当日成交量为20.24万股。Cns Pharmaceuticals, Inc.于2025年6月6日涨2.97%，报1.04美元，该股过去5个交易日涨0.97%，年初至今跌82.67%，过去60日跌58.89%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-06|21.11万|20.95%|20.24万|#|2025-06-05|17.46万|0.56%|17.19万|#|2025-06-04|17.36万|-58.16%|16.69万|#|2025-06-03|41.49万|16.71%|41.11万|#|2025-06-02|35.55万|239.19%|35.31万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607093135a49d833c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607093135a49d833c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2541886886","title":"Cns Pharmaceuticals, Inc.6月5日成交额为17.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541886886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541886886?lang=zh_cn&edition=full","pubTime":"2025-06-06 09:30","pubTimestamp":1749173455,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Cns Pharmaceuticals, Inc.成交额为17.46万美元，成交额较昨日增加0.56%，当日成交量为17.19万股。Cns Pharmaceuticals, Inc.于2025年6月5日跌4.72%，报1.01美元，该股过去5个交易日跌5.61%，年初至今跌83.17%，过去60日跌59.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-05|17.46万|0.56%|17.19万|#|2025-06-04|17.36万|-58.16%|16.69万|#|2025-06-03|41.49万|16.71%|41.11万|#|2025-06-02|35.55万|239.19%|35.31万|#|2025-05-30|10.48万|-59.40%|10.06万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606093246a6fc7f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606093246a6fc7f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2540671042","title":"Cns Pharmaceuticals, Inc.6月2日成交额为35.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540671042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540671042?lang=zh_cn&edition=full","pubTime":"2025-06-03 09:30","pubTimestamp":1748914229,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日，Cns Pharmaceuticals, Inc.成交额为35.55万美元，成交额较昨日增加239.19%，当日成交量为35.31万股。Cns Pharmaceuticals, Inc.于2025年6月2日跌2.91%，报1.0美元，该股过去5个交易日跌9.09%，年初至今跌83.33%，过去60日跌64.03%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-02|35.55万|239.19%|35.31万|#|2025-05-30|10.48万|-59.40%|10.06万|#|2025-05-29|25.81万|-8.61%|24.09万|#|2025-05-28|28.24万|-15.13%|26.09万|#|2025-05-27|33.28万|53.26%|30.79万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603093045a6f7cc3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603093045a6f7cc3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2539533201","title":"Cns Pharmaceuticals, Inc.5月30日成交额为10.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539533201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539533201?lang=zh_cn&edition=full","pubTime":"2025-05-31 09:29","pubTimestamp":1748654997,"startTime":"0","endTime":"0","summary":"美东时间2025年5月30日，Cns Pharmaceuticals, Inc.成交额为10.48万美元，成交额较昨日减少59.40%，当日成交量为10.06万股。Cns Pharmaceuticals, Inc.于2025年5月30日跌3.74%，报1.03美元，该股过去5个交易日跌10.43%，年初至今跌82.83%，过去60日跌58.47%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-30|10.48万|-59.40%|10.06万|#|2025-05-29|25.81万|-8.61%|24.09万|#|2025-05-28|28.24万|-15.13%|26.09万|#|2025-05-27|33.28万|53.26%|30.79万|#|2025-05-23|21.71万|-32.80%|19.67万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531093007a6f40b49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531093007a6f40b49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2539866982","title":"Cns Pharmaceuticals, Inc.5月28日成交额为28.24万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539866982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539866982?lang=zh_cn&edition=full","pubTime":"2025-05-29 09:31","pubTimestamp":1748482267,"startTime":"0","endTime":"0","summary":"美东时间2025年5月28日，Cns Pharmaceuticals, Inc.成交额为28.24万美元，成交额较昨日减少15.13%，当日成交量为26.09万股。Cns Pharmaceuticals, Inc.于2025年5月28日跌2.78%，报1.05美元，该股过去5个交易日跌18.6%，年初至今跌82.5%，过去60日跌52.27%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-28|28.24万|-15.13%|26.09万|#|2025-05-27|33.28万|53.26%|30.79万|#|2025-05-23|21.71万|-32.80%|19.67万|#|2025-05-22|32.31万|0.65%|27.64万|#|2025-05-21|32.10万|-45.59%|25.58万|CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529093351a6f115b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529093351a6f115b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2538997964","title":"Cns Pharmaceuticals, Inc.盘中异动 急速跳水5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538997964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538997964?lang=zh_cn&edition=full","pubTime":"2025-05-28 03:06","pubTimestamp":1748372802,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日03时06分，Cns Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.45%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Imunon, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Forte Biosciences, Inc.涨幅较大，Nucana Plc、Imunon, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为687.37%、426.51%、259.52%，振幅较大的相关个股有Imunon, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为118.97%、74.51%、61.32%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528030642a48eb9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528030642a48eb9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2517440559","title":"Cns Pharmaceuticals, Inc.盘中异动 临近午盘急速拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517440559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517440559?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:55","pubTimestamp":1741193738,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时55分，Cns Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.31%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Chimerix, Inc.、Celularity Inc.、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为918.15%、300.95%、283.88%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306005538abe9dbe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306005538abe9dbe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2516634943","title":"Cns Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.34%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634943?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013046,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分，Cns Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.34%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032244069637afc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032244069637afc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CNSP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cnspharma.com","stockEarnings":[{"period":"1week","weight":0.1803},{"period":"1month","weight":0.1821},{"period":"3month","weight":0.0541},{"period":"6month","weight":-0.1959},{"period":"1year","weight":-0.8775},{"period":"ytd","weight":-0.8922}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CNS Pharmaceuticals, Inc.是一家临床制药公司，于2017年7月27日作为内华达州公司组建，专注于开发用于治疗大脑和中枢神经系统肿瘤的抗癌候选药物，该公司基于根据与休斯顿制药公司（“HPI”）和德克萨斯大学医学博士安德森癌症中心（“UTMDACC”）的许可协议获得许可的知识产权，并根据与Reata制药公司（“Reata”）的合作和资产购买协议拥有。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.196826},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.081635},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.208333},{"month":4,"riseRate":0.333333,"avgChangeRate":0.014485},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010143},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.175576},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.241438},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.118916},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.104014},{"month":10,"riseRate":0.166667,"avgChangeRate":0.050333},{"month":11,"riseRate":0.5,"avgChangeRate":-0.052563},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.145952}],"exchange":"NASDAQ","name":"CNS Pharmaceuticals, Inc.","nameEN":"CNS Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CNS Pharmaceuticals, Inc.(CNSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CNS Pharmaceuticals, Inc.(CNSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CNS Pharmaceuticals, Inc.,CNSP,CNS Pharmaceuticals, Inc.股票,CNS Pharmaceuticals, Inc.股票老虎,CNS Pharmaceuticals, Inc.股票老虎国际,CNS Pharmaceuticals, Inc.行情,CNS Pharmaceuticals, Inc.股票行情,CNS Pharmaceuticals, Inc.股价,CNS Pharmaceuticals, Inc.股市,CNS Pharmaceuticals, Inc.股票价格,CNS Pharmaceuticals, Inc.股票交易,CNS Pharmaceuticals, Inc.股票购买,CNS Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CNS Pharmaceuticals, Inc.(CNSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CNS Pharmaceuticals, Inc.(CNSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}